Tag: bioequivalence
Bioequivalence of Combination Products: Special Testing Challenges Explained
Bioequivalence testing for combination products is far more complex than for single-drug generics. Learn why these formulations face unique challenges, how regulators are responding, and what it means for access to affordable medicines.
View More
Clinical Studies on Generic Drug Efficacy: What the Research Really Shows
Clinical studies show generic drugs are just as effective as brand-name versions for most people. Learn what the research says about bioequivalence, rare exceptions, and when to stick with one brand.
View More
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs
The 80-125% rule ensures generic drugs behave like brand-name versions in the body. It's based on pharmacokinetic data, not pill content. Here's how it works and why it matters.
View MorePopular Posts
